Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
The Korean Journal of Internal Medicine
;
: 1188-1196, 2019.
Article
in English
| WPRIM
| ID: wpr-919128
ABSTRACT
The incidence of colorectal cancer (CRC) has increased. CRC is the third most common cancer and the fourth most common cause of cancer-related deaths in Korea. Palliative chemotherapy can be used to shrink tumors and ease symptoms caused by the cancer when cure is not possible. It is important to identify chemotherapeutic agents that can be used to effectively treat metastatic CRC (mCRC) and thus improve the survival and quality of life of patients with mCRC. This review aimed to evaluate the recent developments in palliative chemotherapy for mCRC and the biological or targeted agents used based on genetic alterations.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
The Korean Journal of Internal Medicine
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS